title: Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry.
abstract: Biomarker discovery using mass spectrometry (MS) has recently seen a significant increase in applications, mainly driven by the rapidly advancing field of metabolomics. Instrumental and data handling advancements have allowed for untargeted metabolite analyses which simultaneously interrogate multiple biochemical pathways to elucidate disease phenotypes and therapeutic mechanisms. Although most MS-based metabolomic approaches are coupled with liquid chromatography, a few recently published studies used matrix-assisted laser desorption (MALDI), allowing for rapid and direct sample analysis with minimal sample preparation. We and others have reported that prostaglandin E3 (PGE3), derived from COX-2 metabolism of the omega-3 fatty acid eicosapentaenoic acid (EPA), inhibited the proliferation of human lung, colon and pancreatic cancer cells. However, how PGE3 metabolism is regulated in cancer cells, particularly human non-small cell lung cancer (NSCLC) cells, is not fully understood. Here, we successfully used MALDI to identify differences in lipid metabolism between two human non-small-cell lung cancer (NSCLC) cell lines, A549 and H596, which could contribute to their differential response to EPA treatment. Analysis by MALDI-MS showed that the level of EPA incorporated into phospholipids in H596 cells was 4-fold higher than A549 cells. Intriguingly, H596 cells produced much less PGE3 than A549 cells even though the expression of COX-2 was similar in these two cell lines. This appears to be due to the relatively lower expression of cytosolic phospholipase A2 (cPLA2) in H596 cells than that of A549 cells. Additionally, the MALDI-MS approach was successfully used on tumor tissue extracts from a K-ras transgenic mouse model of lung cancer to enhance our understanding of the mechanism of action of EPA in the in vivo model. These results highlight the utility of combining a metabolomics workflow with MALDI-MS to identify the biomarkers that may regulate the metabolism of omega-3 fatty acids and ultimately affect their therapeutic potentials.
authors: Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
authors: David A
authors: DA
authors: Pirman
authors: Ekem
authors: E
authors: Efuet
authors: Xiao-Ping
authors: XP
authors: Ding
authors: Yong
authors: Y
authors: Pan
authors: Lin
authors: L
authors: Tan
authors: Susan M
authors: SM
authors: Fischer
authors: Raymond N
authors: RN
authors: DuBois
authors: Peiying
authors: P
authors: Yang
mesh_terms: D000527:Alprostadil / Q000031:analogs & derivatives* / Q000378:metabolism; D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism*; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D055432:Metabolomics; D051379:Mice; D008822:Mice, Transgenic; D009928:Organ Specificity; D054467:Phospholipases A2 / Q000235:genetics / Q000378:metabolism; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics / Q000378:metabolism; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: C033246:prostaglandin E3; D015118:Eicosapentaenoic Acid; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D054467:Phospholipases A2; D016283:Proto-Oncogene Proteins p21(ras); D000527:Alprostadil
references: Nucleic Acids Res. 2009 Jul;37(Web Server issue):W652-60
references: 19429898
references: J Lipid Res. 2004 Jun;45(6):1030-9
references: 14993240
references: J Am Soc Mass Spectrom. 2010 Mar;21(3):338-47
references: 19926301
references: J Proteomics. 2012 Aug 30;75(16):5113-5121
references: 22634082
references: Mol Biosyst. 2008 Jun;4(6):562-70
references: 18493654
references: J Biol Chem. 2001 May 25;276(21):18075-81
references: 11278548
references: Anal Chem. 2006 Apr 1;78(7):2465-9
references: 16579637
references: J Lipid Res. 2011 Aug;52(8):1551-60
references: 21508254
references: Carcinogenesis. 2008 Apr;29(4):790-6
references: 18024478
references: Cancer Res. 2012 Feb 1;72(3):645-54
references: 22139378
references: Anal Chem. 2010 Sep 1;82(17):7343-50
references: 20681559
references: Anal Biochem. 2002 Sep 1;308(1):168-77
references: 12234478
references: PLoS One. 2009 Nov 05;4(11):e7731
references: 19890392
references: J Proteome Res. 2012 Mar 2;11(3):1996-2003
references: 22224404
references: Bioanalysis. 2011 Nov;3(21):2427-41
references: 22074284
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Aug;855(1):98-103
references: 17369111
references: Nat Protoc. 2011 Jun;6(6):743-60
references: 21637195
references: Anal Chem. 2011 Nov 1;83(21):8329-36
references: 21942412
references: Anal Chem. 2010 Apr 1;82(7):2621-5
references: 20196536
references: Cancer Res. 1988 Sep 1;48(17):4790-4
references: 2842039
references: J Natl Cancer Inst. 1995 Apr 19;87(8):587-92
references: 7752256
references: Br J Cancer. 1994 May;69(5):826-32
references: 8180010
references: Angew Chem Int Ed Engl. 2010 Aug 9;49(34):5953-6
references: 20602384
references: Nat Med. 2002 Mar;8(3):289-93
references: 11875501
references: J Proteomics. 2011 Jun 10;74(7):982-92
references: 21440690
references: Mech Ageing Dev. 2005 Jan;126(1):177-85
references: 15610777
references: Nat Methods. 2007 Oct;4(10):828-33
references: 17901873
references: Anal Chem. 1997 Dec 1;69(23):4751-60
references: 9406525
references: Biochim Biophys Acta. 2011 Nov;1811(11):970-5
references: 21571091
references: Anal Chem. 2009 Jul 1;81(13):5557-60
references: 19514699
references: Science. 2005 Dec 2;310(5753):1504-10
references: 16293724
references: Anal Chem. 2008 Jul 15;80(14):5648-53
references: 18564854
references: Prostaglandins Leukot Essent Fatty Acids. 2006 Dec;75(6):385-95
references: 17011176